NASDAQ:IXHL Incannex Healthcare Q4 2026 Earnings Report $3.38 -0.03 (-0.74%) As of 12:04 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Incannex Healthcare EPS ResultsActual EPS-$0.15Consensus EPS $0.13Beat/MissMissed by -$0.28One Year Ago EPSN/AIncannex Healthcare Revenue ResultsActual RevenueN/AExpected Revenue$0.20 millionBeat/MissN/AYoY Revenue GrowthN/AIncannex Healthcare Announcement DetailsQuarterQ4 2026Date9/26/2026TimeBefore Market OpensConference Call DateFriday, September 25, 2026Conference Call Time7:00AM ETUpcoming EarningsIncannex Healthcare's Q1 2027 earnings is estimated for Friday, September 25, 2026, based on past reporting schedulesConference Call ResourcesAnnual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsAnnual report(10-K) Incannex Healthcare Earnings HeadlinesIncannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital PositionSeptember 9, 2026 | globenewswire.comIncannex Healthcare Doses First Patient in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep ApneaAugust 25, 2026 | quiverquant.comQReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.September 25 at 1:00 AM | Base Camp Trading (Ad)Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42XAugust 25, 2026 | globenewswire.comIncannex Healthcare Inc.August 15, 2026 | cnn.comIncannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026August 11, 2026 | finance.yahoo.comSee More Incannex Healthcare Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Incannex Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Incannex Healthcare and other key companies, straight to your email. Email Address About Incannex HealthcareIncannex Healthcare (NASDAQ:IXHL) Limited (NASDAQ: IXHL) is a clinical-stage biotechnology company developing pharmaceutical products and therapies for conditions with significant unmet medical needs. The company’s research focuses on cannabinoid- and psychedelic-assisted treatments, with programs addressing sleep-disordered breathing, pain, inflammation, mental health and other complex disorders. One of Incannex’s principal programs is IHL-42X, an investigational combination of dronabinol and acetazolamide being developed for obstructive sleep apnea. The company has also pursued cannabinoid-based candidates for inflammatory and fibrotic diseases, pain conditions and traumatic brain injury, as well as psychedelic-assisted therapies for psychiatric disorders such as generalized anxiety disorder. These products remain investigational and are subject to clinical and regulatory review. Founded in Australia, Incannex has conducted research and clinical development activities in Australia and the United States. The company’s securities trade on the Nasdaq Capital Market under the symbol IXHL, and it has historically been led by Managing Director and Chief Executive Officer Joel Latham. Incannex’s development strategy is centered on advancing its drug candidates through clinical trials and, where appropriate, seeking regulatory approval and commercialization partnerships.View Incannex Healthcare ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Super Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Space Stocks to Watch as SpaceX Reshapes the Launch MarketOil May Be Stronger Than It Looks—And Diamondback Is on SaleBlackBerry Shifts Gears With Coretura DealCintas Raises Guidance as a Major Catalyst Moves Closer3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure Builds Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
